OR7E102P

Across TCGA pan-cancer cohorts, OR7E102P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated OR7E102P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR7E102P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E102P expression acts as an unfavorable survival marker, although some lineages such as ACC and MESO show a favorable association.

COAD, UCEC, and KIRC are the cancer types where OR7E102P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.711	0.831	<.001	130	view →
UCEC	OS	Tertile	All	0.495	0.731	.001	64	view →
KIRC	OS	Tertile	II,III,IV	0.405	0.649	<.001	59	view →
READ	OS	Tertile	III,IV	0.647	1.000	.001	43	view →
UVM	OS	Quartile	All	0.566	0.865	.001	41	view →
ACC	DFS	Quartile	All	0.893	0.281	<.001	40	view →
MESO	OS	Median	III,IV	0.837	0.253	<.001	28	view →
CESC	OS	Tertile	IV	0.844	0.102	.015	26	view →
LAML	DFS	Tertile	All	0.446	0.622	.021	24	view →
LIHC	DFS	Median	II,III,IV	0.505	0.345	.005	18	view →
LUAD	OS	Quartile	II,III,IV	0.562	0.173	.011	12	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

OR7E102P–COAD (DFS)

Open the COAD breakdown →